UNSPSC 51123001: Ajmaline

This classification denotes an antiarrhythmic agent with the molecular formula C20H26N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1PON08459R, chemically known as ajmalan-17,21-diol, (17r,21.alpha.)- but more generally known as ajmaline, which bears US NIH Compound Identifier 2073. Ajmaline comes in many forms, including aspartate, ethanolate, ethylphenylbarbiturate, n-oxide, and phenylbarbiturate.

UNSPSC 51123001 Ajmaline is a Commodity code covering pharmaceutical products used in emergency medical care. State and local governments—primarily fire departments and emergency medical services—procure advanced life support medications under this code, including injectable vasopressors, antiarrhythmics, and other acute-care drugs. The City of Tampa's Purchasing Department recently solicited sealed bids for Advanced Life Support Medications (Bid No. 26-P-00188) to supply Tampa Fire Rescue with 370 units of Labetalol HCI 100mg vials, 1,810 units of Epinephrine 1:10,000 injections, 330 units of Adenosine 6mg vials, and 1,020 units of Diltiazem 25mg vials, with an estimated contract value of $40,000.00. Vendors must guarantee medications maintain expiration dates nine months or longer from acceptance, deliver within ten calendar days of order receipt, provide comprehensive Safety Data Sheets compliant with OSHA Hazard Communication Standards, and submit accessibility conformance documentation to WCAG 2.2 Level AA and Section 508 standards. The contract runs one year from award with two renewal options and potential unilateral extensions of up to three additional 30-day periods. Tampa designated this opportunity with a Small Local Business Enterprise (SLBE) sheltered-market set-aside offering a 5 percent bid discount for SLBE participation up to $10,000.

The City of Tampa in Hillsborough County, Florida represents the primary recent activity identified under this code. Electronic bids for the Tampa Fire Rescue procurement closed on April 8, 2026, via the OpenGov eProcurement Portal, with award to be made to the lowest responsive, responsible bidder within 120 days of bid opening. No other state or local jurisdictions appear in the recent-opportunities block; geographic spread and issuing-body mix beyond Tampa cannot be determined from the source.